Sleep Apnea Syndrome and the Cardiovascular Diseases.
10.7599/hmr.2013.33.4.221
- Author:
Jinho SHIN
1
Author Information
1. Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. jhs2003@hanyang.ac.kr
- Publication Type:Review
- Keywords:
Sleep Apnea Syndromes;
Myocardial Infarction;
Stroke;
Heart Failure;
Hypertension
- MeSH:
Anoxia;
Cardiovascular Diseases*;
Continuous Positive Airway Pressure;
Coronary Artery Disease;
Dyslipidemias;
Heart Failure;
Hypertension;
Longitudinal Studies;
Myocardial Infarction;
Obesity;
Oxidative Stress;
Prognosis;
Risk Factors;
Sleep Apnea Syndromes*;
Smoke;
Smoking;
Stress, Psychological;
Stroke
- From:Hanyang Medical Reviews
2013;33(4):221-226
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Sleep apnea syndrome (SAS) has known to be associated with obesity, hypoxemia, sympathetic activation, and hypertension. In addition, SAS is associated with various mechanisms involved in cardiovascular diseases, such as oxidative stress, dyslipidemia, smoking, and psychological stress. In recent prospective observation studies, SAS is known to be a risk factor for cardiovascular diseases, i.e., heart failure, stroke, and coronary artery diseases. The association with heart failure was most evident. In some participants in the longitudinal study applied with continuous positive airway pressure (CPAP) treatment, SAS was not associated with prognosis. With the viewpoints in the current standard of cardiovascular medicine, there seems to be few evidence showing that CPAP treatment could prevent or improve cardiovascular outcome. Detailed review of the limitations of the prospective observational studies suggests that more sophisticated measurement of the clinical outcomes and adjustment of confounding factors will be required in the future studies. And for the clinical application, more evidence of CPAP treatment on the cardiovascular outcomes are mandatory.
